Endothelial Dysfunction as the Common Pathway Linking Obesity, Hypertension and Atherosclerosis

Cited by (101)

Items 101–101 of 101

  1. Dapagliflozin attenuates progression from prefrailty to frailty in patients with hypertension and chronic kidney disease
    Pasquale Mone, Davide Viggiano, Antonella Pansini, Maria Virginia Soldovieri, Giada Sabatelli, Valeria Visco, Gaetano Macina, Eugenio Boccalone, Michele Ciccarelli, Giuseppe Nicola Martinelli et al. · 2026 · Journal of Clinical Investigation